Evaluation of the Prevalence of Macrosomia and the Maternal Risk Factors

Document Type: Original Article

Authors

1 Asociate professor f nutrition, Lorestan university of Medical Sciences

2 department f nutrition, lorestan university of medical sciences

3 department of nutrition, lorestan university of medical sciences

4 department of English literature,Chamran university

Abstract

Abstract
Background: Macrosomia is a term applied to newborns with a birth weight of 4000 gr or above. Perinatal mortality and morbidity is increased in fetal macrosomia. Clavicular fracture, injury to brachial plexus, and hypoglycemia are important side effects. Mother’s age, body mass index of mother, weight gain in pregnancy, mother’s height, diabetes, history of macrocosmic delivery, gestational age, parity, and fetal sex are factors causing macrosomia. The purpose of this cross-sectional study was to evaluate the frequency and risk factors of macrosomia in Asalian hospital of Khorramabad in the summer of 2010.
Methods: The data collection instrument was a questionnaire containing 10 variables as the risk factors of macrosomia. The data were analyzed using the SPSS software.
Results: 59 cases of macrosomia were found in 500 living births. The results showed that the frequency of macrosomia was 11.8%. 69.5% of the neonates were male and 30.5% were female. Maternal risk factors were mother's age at pregnancy, mother's obesity (BMI>=30), weight gain more than 18 kg during pregnancy, history of diabetes mellitus, history of macrosomia, prolonged gestational age, and multiparity (parity>=5). There was no significant relationship between mother's job and macrosomia.
Conclusion: The prevalence of macrosomia in Khorramabad was high (11.8%). Preventing pregnancy in mothers over 35 years of age by contraception ways, preventing maternal obesity before pregnancy, and control of blood glucose during pregnancy by suitable diet and insulin therapy are recommended to prevent macrosomia.

Keywords


  1. Hamilton BE, Martin JA, Ventura SJ. Births: preliminary data for 2005. National vital statistics reports. 2006;55(11):1-18.
  2. Lawlor D, Fraser A, Lindsay R, Ness A, Dabelea D, Catalano P, et al. Association of existing diabetes, gestational diabetes and glycosuria in pregnancy with macrosomia and offspring body mass index, waist and fat mass in later childhood: findings from a prospective pregnancy cohort. Diabetologia. 2010;53(1):89-97.
  3. King J, Korst L, Miller D, Ouzounian J. 125: Increased maternal and neonatal morbidity associated with suspected fetal macrosomia. Acta Obstet Gynecol Scand. 2012;206(1):S67-8.
  4. Bjørstad AR, IRGENS‐HANSEN K, Daltveit AK, Irgens LM. Macrosomia: mode of delivery and pregnancy outcome. Acta obstetricia et gynecologica Scandinavica. 2010; 89(5):664-9.
  5. Voldner N, Qvigstad E, Frøslie KF, Godang K, Henriksen T, Bollerslev J. Increased risk of macrosomia among overweight women with high gestational rise in fasting glucose. J Matern Fetal Neonatal Med. 2010;23(1):74-81.
  6. Ouzounian J, Hernandez G, Korst L, Montoro M, Battista L, Walden C, et al. Pre-pregnancy weight and excess weight gain are risk factors for macrosomia in women with gestational diabetes. J Perinatol. 2011;31(11):717-21.
  7. Koyanagi A, Zhang J, Dagvadorj A, Hirayama F, Shibuya K, Souza JP, et al. Macrosomia in 23 developing countries: an analysis of a multicountry, facility-based, cross-sectional survey. Lancet. 2013; 381(9865):476-83.
  8. Koch L. Reproductive endocrinology: Macrosomia in developing countries. Nat Rev Endocrinol. 2013 ;9(3):130
  9. Salem W, Adler A, Lee C, Smith G. Maternal waist to hip ratio is a risk factor for macrosomia. BJOG. 2012;119(3):291-7.
10. King JR, Korst LM, Miller DA, Ouzounian JG. Increased composite maternal and neonatal morbidity associated with ultrasonographically suspected fetal macrosomia. J Matern Fetal Neonatal Med.  2012;25(10):1953-9.

11. Heiskanen N, Raatikainen K, Heinonen S. Fetal macrosomia–a continuing obstetric challenge. Biol Neonate. 2006;90(2):98-103.

12. Cheng YK-Y, Lao TT, Sahota DS, Leung VK-T, Leung TY. Use of birth weight threshold for macrosomia to identify fetuses at risk of shoulder dystocia among Chinese populations. Int J Gynaecol Obstet. 2013;120(3):249-53

13. Young BC, Ecker JL. Fetal Macrosomia and Shoulder Dystocia in Women with Gestational Diabetes: Risks Amenable to Treatment?. Curr Diab Rep. 2013;13(1):12-8.

14. Back M. Improving the Ultrasound and Clinical Diagnosis of Macrosomia to Reduce the Primary Cesaerean Delivery Rate[Master thesis].Philadelphia: Jefferson University; 2013.

15. Swank M, Caughey A, Farinelli C, Main E, Melsop K, Gilbert W, et al. 437: The impact of change in pregnancy body mass index on macrosomia. American Journal of Obstetrics & Gynecology. 2013;208(1):S190-S.

16. Fanaroff A. Ju H, Chadha Y, Donovan T, O'Rourke P. Fetal macrosomia and pregnancy outcomes. Aust N Z J Obstet Gynaecol. 2009;49(5):504–9.

17. Mohajeri N. Effects of landscape constraints on street patterns in cities: Examples from Khorramabad, Iran. Applied Geography. 2012;34:10-20.

18. Gharibzadeh S, Javaheri H, Asgari Z, Parviz M. Evaluating of the risk factors of macrosomia in labours performed in baharloo hospital during two years (1380-1381). Annals of Military And Health Sciences Research . 2005; 3(9):709-13.

19. Fakhri M. Evaluating of the risk factors of macrosomia in sari city in1997; journal of Medical Sciences and health Service; 1998, 19: 24-30 (in Persian).

20. Fakhri M, Askarian M. Maternal and infant complications in macrosomia by method of delivery. Journal of Shahid Sadoughi University of Medical Sciences and Health Services. 2000; 8(2):62-9.

21. Mamouri Gh, Behmanesh F. Study the incidence of embryonic macrosomia, factors and pathogenecity of macrosomic new born in Gheam Hospital. Journal of Mashhad Medical School. 2008 (66):21-7. (Persian).

22. Eftekhari N, Mirzaei F. Prevalence of macrosomia and associated factors among pregnant women. The Journal of Ghazvin University of Medical Sciences. 1999;3(3):56-60.(Persian).

23. Metzger E FR. Gestational diabetes and obesity lead to macrosomia.  American diabetes association 70th scientific sessions 2010. p. 154-60.

24. Asplund CA, Seehusen DA, Callahan TL, Olsen C. Percentage change in antenatal body mass index as a predictor of neonatal macrosomia. Ann Fam Med. 2008;6(6):550-4.

25. Saberi F SZ, Abedzade M. The prevalence of fetal macrosomia and post-term delivery and multiparity as its risk factors.  FEYZ . 2002;6(2):65-9.

26. Anzaku AS, Musa J. Prevalence and associated risk factors for gestational diabetes in Jos, North-central, Nigeria. Arch Gynecol Obstet. 2013;287(5):1-5.

27. Meshari A, De Silva S, Rahman I. Fetal macrosomia—maternal risks and fetal outcome. Int J Gynaecol Obstet.  1990;32(3):215-22.

28. Ekabua JE, Ukombe EB, Agan TU, Iklaki CU, Etuk SJ, Itam IH. A Seven year clinical review of macrosomic births in Calabar. Mary Slessor Journal of Medicine. 2005;4(1):32-6.

29. O'Reilly J, Riley S, Critchley H, Seckl J, Reynolds R. Reduced glucocorticoid action in obese pregnancy associates with increased birth weight and macrosomia. Endocrine Abstracts .2013; 31: 143.

30. Yulia A, Shakur F, Matar M. PL. 92 Management of Macrosomia in Non Diabetic Women in District General Hospital. Is Induction of Labour Justified?. Arch Dis Child Fetal Neonatal Ed. 2013; 98:A80

31. Garabedian C, Saleron J, Vambergue A, Deruelle P. 251: Prediction of macrosomia in pregnancies with pre-gestational diabetes with serial fetal sonographic measurements of soft tissues and liver. American Journal of Obstetrics & Gynecology. 2013;208(1):S115.